Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines

Completed · Phase 1

Conditions studied: Bacterial Infections, Group B Streptococcus

In brief

The purpose of this study is to test the safety and favorable immune response to an anti-streptococcal vaccine (a vaccine that treats a common bacterial infection) in healthy non-pregnant women. Group B Streptococcus (GBS) continues to be the single most frequent cause of life-threatening bacterial infection during the first 2 months of life. Further, GBS pregnancy-related morbidity afflicts more than 50,000 women annually in the US. Therefore, active immunization of women is an appealing strategy for the prevention of GBS disease in pregnant women and their infants during the first 3 months of infant life.

Key facts

Study ID
NCT00008853
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
People needed
65
Expected to finish
2005-11-01
Last updated by the study team
2010-08-27

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.